Applications

1192 – Percutaneous Reconstruction of an Insufficient Mitral Valve through Tissue Approximation using Transvenous/ Transeptal Techniques

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome Not supported

Application details

Reason for application

New MBS item.

Service or technology in this application

Percutaneous reconstruction of an insufficient mitral valve through tissue approximation using transvenous/transeptal techniques is performed while the heart is beating, which better allows the identification of the origin of mitral regurgitation (MR).

Type: Therapeutic

Medical condition this application addresses

MR occurs when the leaflets (or flaps) of the heart’s mitral value do not close properly and leak. The mitral valve is a one-way valve that separates the left atrium (a chamber in the heart which collects blood from the lungs) from the left ventricle (a chamber in the heart which pumps blood to the rest of the body). During pumping, the leak in the mitral valve causes blood to flow backwards (MR) into the left atrium, thereby decreasing blood flow to the body. To maintain blood flow to the body and compensate for the MR, the left ventricle must pump harder. Back flow due to MR places an extra burden on the left ventricle and lungs. Eventually, this burden can cause other problems such as: stroke, sudden death, irregular heartbeat, increasing damage to the heart muscle (progressive myocardial injury); inability to maintain adequate circulation of blood (congestive heart failure).

Meetings to consider this application

  • PASC meeting: 1 – 2 December 2012
  • ESC meeting: 11 – 12 October 2012
  • MSAC meeting: 29 – 30 November 2012